[go: up one dir, main page]

SE0003045D0 - New method - Google Patents

New method

Info

Publication number
SE0003045D0
SE0003045D0 SE0003045A SE0003045A SE0003045D0 SE 0003045 D0 SE0003045 D0 SE 0003045D0 SE 0003045 A SE0003045 A SE 0003045A SE 0003045 A SE0003045 A SE 0003045A SE 0003045 D0 SE0003045 D0 SE 0003045D0
Authority
SE
Sweden
Prior art keywords
immunoglobulins
new method
solution
provides
amount sufficient
Prior art date
Application number
SE0003045A
Other languages
English (en)
Inventor
Daniel Norman
Marie-Louise Johansson
Bjoern Aakesson
Lena Nyberg
Marie Paulsson
Original Assignee
Probi Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probi Ab filed Critical Probi Ab
Priority to SE0003045A priority Critical patent/SE0003045D0/sv
Publication of SE0003045D0 publication Critical patent/SE0003045D0/sv
Priority to DE60137062T priority patent/DE60137062D1/de
Priority to AU2001282806A priority patent/AU2001282806B2/en
Priority to NZ524445A priority patent/NZ524445A/en
Priority to PCT/SE2001/001836 priority patent/WO2002018442A1/en
Priority to AU8280601A priority patent/AU8280601A/xx
Priority to EP01961546A priority patent/EP1322669B1/en
Priority to US10/362,358 priority patent/US7220409B2/en
Priority to AT01961546T priority patent/ATE417862T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/19Dairy proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L7/00Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10Cereal-derived products
    • A23L7/104Fermentation of farinaceous cereal or cereal material; Addition of enzymes or microorganisms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Beans For Foods Or Fodder (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Seeds, Soups, And Other Foods (AREA)
  • Dairy Products (AREA)
SE0003045A 2000-08-29 2000-08-29 New method SE0003045D0 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE0003045A SE0003045D0 (sv) 2000-08-29 2000-08-29 New method
DE60137062T DE60137062D1 (de) 2000-08-29 2001-08-29 Stabilisierung von Immunglobulinen bei niedrigem pH durch Getreide oder Haferflockensuppe oder Hafermehl
AU2001282806A AU2001282806B2 (en) 2000-08-29 2001-08-29 Stabilisation of immunoglobulins at a low pH
NZ524445A NZ524445A (en) 2000-08-29 2001-08-29 A health drink comprising probiotic bacteria and immunoglobulins that have been stabilised by cereals or hydrolysed cereal products
PCT/SE2001/001836 WO2002018442A1 (en) 2000-08-29 2001-08-29 Stabilisation of immunoglobulins at a low ph
AU8280601A AU8280601A (en) 2000-08-29 2001-08-29 Stabilisation of immunoglobulins at a low ph
EP01961546A EP1322669B1 (en) 2000-08-29 2001-08-29 Stabilisation of immunoglobulins at low pH by adding cereals or oatmeal soup or oat flour
US10/362,358 US7220409B2 (en) 2000-08-29 2001-08-29 Stabilization of immunoglobulins at low pH
AT01961546T ATE417862T1 (de) 2000-08-29 2001-08-29 Stabilisierung von immunglobulinen bei niedrigem ph durch getreide oder haferflockensuppe oder hafermehl

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0003045A SE0003045D0 (sv) 2000-08-29 2000-08-29 New method

Publications (1)

Publication Number Publication Date
SE0003045D0 true SE0003045D0 (sv) 2000-08-29

Family

ID=20280816

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0003045A SE0003045D0 (sv) 2000-08-29 2000-08-29 New method

Country Status (8)

Country Link
US (1) US7220409B2 (sv)
EP (1) EP1322669B1 (sv)
AT (1) ATE417862T1 (sv)
AU (2) AU2001282806B2 (sv)
DE (1) DE60137062D1 (sv)
NZ (1) NZ524445A (sv)
SE (1) SE0003045D0 (sv)
WO (1) WO2002018442A1 (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040033228A1 (en) 2002-08-16 2004-02-19 Hans-Juergen Krause Formulation of human antibodies for treating TNF-alpha associated disorders
MY150740A (en) * 2002-10-24 2014-02-28 Abbvie Biotechnology Ltd Low dose methods for treating disorders in which tnf? activity is detrimental
WO2005029979A1 (de) * 2003-09-19 2005-04-07 Bomba Energia Getränkevertriebs GmbH Mineral-, vitamin- und aminosäurehaltiges getränk
SI2277524T1 (sl) * 2005-09-28 2016-02-29 Nordisk Rebalance A/S Zdravljenje sindroma razdražljivega črevesja z uporabo probiotičnih bakterij in fermentiranih žit kot efektorjev zdravljenja
BRPI0616960B8 (pt) * 2005-10-06 2021-05-25 Probi Ab uso de lactobacilo para o tratamento de infecções virais
US7794774B2 (en) * 2005-11-07 2010-09-14 The Quaker Oats Company Long shelf-life high moisture content cereal products
FR2909526B1 (fr) * 2006-12-08 2011-04-01 Gervais Danone Sa Produit alimentaire comprenant des probiotiques et un monoacide faible protone
US8883146B2 (en) 2007-11-30 2014-11-11 Abbvie Inc. Protein formulations and methods of making same
JP2012510468A (ja) * 2008-11-28 2012-05-10 アボット・ラボラトリーズ 安定な抗体組成物およびこれを安定させるための方法
CA2760185A1 (en) * 2009-05-04 2010-11-11 Abbott Biotechnology Ltd. Stable high protein concentration formulations of human anti-tnf-alpha antibodies
BR112013011699B1 (pt) 2010-11-11 2019-04-24 Abbvie Biotechnology Ltd FORMULAÇÕES AQUOSAS LÍQUIDAS, SERINGA PRÉ-CHEIA OU DISPOSITIVO AUTOINJETOR E USO DAS DITAS FORMULAÇÕES PARA TRATAR UM DISTÚRBIO ASSOCIADO À ATIVIDADE DE TNFa COMPROMETIDA
WO2019045576A1 (en) * 2017-09-04 2019-03-07 Innovative Dairy Consultants Limited BIOACTIVE DAIRY PRODUCTS AND PROCESSES FOR THEIR MANUFACTURE
WO2022148549A1 (en) 2020-01-14 2022-07-14 Babylat Gmbh Apparatus and method for obtaining protein-enriched fractions from breast milk

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3640729A (en) * 1969-05-08 1972-02-08 Nabisco Inc Instant oat cereal product
CH627079A5 (en) * 1977-04-15 1981-12-31 Nestle Sa Process for preparing a protein concentrate containing immunological factors of milk origin
US4402938A (en) * 1980-05-29 1983-09-06 Impro Products, Inc. Food and the method of extracting the same from colostrum and milk
US4477432A (en) * 1981-05-01 1984-10-16 Cutter Laboratories, Inc. Oral immune globulin
US5017372A (en) * 1986-04-14 1991-05-21 Medicis Corporation Method of producing antibody-fortified dry whey
SE463796B (sv) 1988-03-09 1991-01-28 Carl Erik Albertsson Foerfarande foer framstaellning av en naeringskomposition och daervid framstaelld naeringskomposition
EP0417821A1 (en) * 1989-09-13 1991-03-20 Duphar International Research B.V Method of stabilising colostrum for immunochemical examination
DE4026365A1 (de) * 1990-08-21 1992-02-27 Biotest Pharma Gmbh Sterilfiltrierte kolostralmilch
AU651219B2 (en) * 1991-07-02 1994-07-14 Fuji Oil Company Limited Protein dispersant comprising water-soluble hemicellulose
US6096870A (en) * 1994-01-05 2000-08-01 Sepragen Corporation Sequential separation of whey
US5531989A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Immunoglobulin and fiber-containing composition for human gastrointestinal health
AUPN642795A0 (en) * 1995-11-08 1995-11-30 Northfield Laboratories Pty Ltd Dairy compositions and methods of preparing same
WO2000047063A2 (en) * 1999-02-12 2000-08-17 Natura, Inc. Combined milk, juice, and cereal grain/polysaccharide blend for consumption and methods for production thereof

Also Published As

Publication number Publication date
NZ524445A (en) 2004-05-28
AU8280601A (en) 2002-03-13
WO2002018442A1 (en) 2002-03-07
US20040028667A1 (en) 2004-02-12
AU2001282806B2 (en) 2007-05-10
US7220409B2 (en) 2007-05-22
ATE417862T1 (de) 2009-01-15
EP1322669B1 (en) 2008-12-17
EP1322669A1 (en) 2003-07-02
DE60137062D1 (de) 2009-01-29

Similar Documents

Publication Publication Date Title
SE0003045D0 (sv) New method
DE60218313D1 (de) Neue betainhaltige nahrungsmittelprodukte
ATE451022T1 (de) Arabinogalactan und mineralzusatzstoff enthaltende getränkezusammensetzungen
DE60201824D1 (de) Nahrungsergänzung zur behandlung von makula degeneration
ATE236532T1 (de) Saures getränk
BR0313548A (pt) Produto alimentìcio com base em cereal compreendendo dha e/ou epa
DK0677249T3 (da) Saltforstærkede fødevarer
ATE361001T1 (de) Nahrungsmittel enthaltend vitamin k2
ATE154203T1 (de) Mittel zur verbesserung des salzgeschmacks
TW200531636A (en) Packaged, tea-based beverages
ATE429818T1 (de) Verfahren zur stabilisierung von ubichinol in lebensmitteln
DE50304868D1 (de) Verwendung von mandelsäurealkylamiden als aromastoffe
ATE260570T1 (de) Gekochte, angesäuerte nudeln
PL369304A1 (en) Toilet bar having a latent acidifier
HUP0300831A2 (hu) Eljárás és kompozíció ásványi anyagok ízének elfedésére
ID22334A (id) Produk beras
ES2195586T3 (es) Almidon modificado, estable respecto a la sal.
DE60233128D1 (de) Riechstoff- und geschmackstoffzusammensetzungen
DE50205466D1 (de) Substituierte 2,5-diamidoindole als ece-inhibitoren zur behandlung von kardiovaskulären erkrankungen
DK1392126T3 (da) Fremgangsmåde til forbedring af et proteinprodukt
ATE326861T1 (de) Essbarer brotaufstrich
WO2002057246A3 (en) Inhibitors of cruzipain and other cysteine proteases
DE60201440D1 (de) Aryl-8-azabicyclo[3.2.1]octanes für die behandlung von depression
ATE382271T1 (de) Verwendung von 2,4,7-decatrienal als duft- oder aromastoff
BR0210749B1 (pt) Composição de fragrância e sabor, produtos fragrante e flavorizante, método para melhorar a referida composição e compostos